SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-002584
Filing Date
2019-03-29
Accepted
2019-03-29 07:20:44
Documents
3
Period of Report
2019-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 38513
2 EX-99.1 ex-99d1.htm EX-99.1 133173
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 13499
  Complete submission text file 0001558370-19-002584.txt   191626
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 19713950
SIC: 2834 Pharmaceutical Preparations